Frederick, MD., Aug. 14, 2024 -- Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan...
Art Pappas will be participating in a workshop titled "Getting Corporate Formation Right" at BioCentury Grand Rounds 2024.
Event | 09. 10. 2024
Art Pappas will be participating in a breakfast workshop titled "Getting Corporate Formation Right" at BioCentury Grand Rounds on Tuesday, September 10th in Nashville, TN.
